181 related articles for article (PubMed ID: 15964823)
1. Hepatocyte growth factor activator inhibitor type 1 (HAI-1) is required for branching morphogenesis in the chorioallantoic placenta.
Tanaka H; Nagaike K; Takeda N; Itoh H; Kohama K; Fukushima T; Miyata S; Uchiyama S; Uchinokura S; Shimomura T; Miyazawa K; Kitamura N; Yamada G; Kataoka H
Mol Cell Biol; 2005 Jul; 25(13):5687-98. PubMed ID: 15964823
[TBL] [Abstract][Full Text] [Related]
2. Hepatocyte growth factor activator inhibitor-1 (HAI-1) is essential for the integrity of basement membranes in the developing placental labyrinth.
Fan B; Brennan J; Grant D; Peale F; Rangell L; Kirchhofer D
Dev Biol; 2007 Mar; 303(1):222-30. PubMed ID: 17174946
[TBL] [Abstract][Full Text] [Related]
3. Matriptase inhibition by hepatocyte growth factor activator inhibitor-1 is essential for placental development.
Szabo R; Molinolo A; List K; Bugge TH
Oncogene; 2007 Mar; 26(11):1546-56. PubMed ID: 16983341
[TBL] [Abstract][Full Text] [Related]
4. Defect of hepatocyte growth factor activator inhibitor type 1/serine protease inhibitor, Kunitz type 1 (Hai-1/Spint1) leads to ichthyosis-like condition and abnormal hair development in mice.
Nagaike K; Kawaguchi M; Takeda N; Fukushima T; Sawaguchi A; Kohama K; Setoyama M; Kataoka H
Am J Pathol; 2008 Nov; 173(5):1464-75. PubMed ID: 18832587
[TBL] [Abstract][Full Text] [Related]
5. Hepatocyte growth factor activator inhibitor type 2 lacking the first Kunitz-type serine proteinase inhibitor domain is a predominant product in mouse but not in human.
Itoh H; Kataoka H; Hamasuna R; Kitamura N; Koono M
Biochem Biophys Res Commun; 1999 Feb; 255(3):740-8. PubMed ID: 10049781
[TBL] [Abstract][Full Text] [Related]
6. Expression of hepatocyte growth factor activator inhibitor type 2 (HAI-2) in human testis: identification of a distinct transcription start site for the HAI-2 gene in testis.
Yamauchi M; Itoh H; Naganuma S; Koono M; Hasui Y; Osada Y; Kataoka H
Biol Chem; 2002 Dec; 383(12):1953-7. PubMed ID: 12553733
[TBL] [Abstract][Full Text] [Related]
7. Mouse hepatocyte growth factor (HGF) activator inhibitor type 2 lacking the first Kunitz domain potently inhibits the HGF activator.
Kataoka H; Itoh H; Nuki Y; Hamasuna R; Naganuma S; Kitamura N; Shimomura T
Biochem Biophys Res Commun; 2002 Jan; 290(3):1096-100. PubMed ID: 11798188
[TBL] [Abstract][Full Text] [Related]
8. Localization of hepatocyte growth factor activator inhibitor type 1 in Langhans' cells of human placenta.
Kataoka H; Meng JY; Itoh H; Hamasuna R; Shimomura T; Suganuma T; Koono M
Histochem Cell Biol; 2000 Dec; 114(6):469-75. PubMed ID: 11201608
[TBL] [Abstract][Full Text] [Related]
9. Diverse roles of hepatocyte growth factor activator inhibitor type 1 (HAI-1) in the growth of glioblastoma cells in vivo.
Miyata S; Uchinokura S; Fukushima T; Hamasuna R; Itoh H; Akiyama Y; Nakano S; Wakisaka S; Kataoka H
Cancer Lett; 2005 Sep; 227(1):83-93. PubMed ID: 16051034
[TBL] [Abstract][Full Text] [Related]
10. Expression of the serine protease matriptase and its inhibitor HAI-1 in epithelial ovarian cancer: correlation with clinical outcome and tumor clinicopathological parameters.
Oberst MD; Johnson MD; Dickson RB; Lin CY; Singh B; Stewart M; Williams A; al-Nafussi A; Smyth JF; Gabra H; Sellar GC
Clin Cancer Res; 2002 Apr; 8(4):1101-7. PubMed ID: 11948120
[TBL] [Abstract][Full Text] [Related]
11. Regulation of pericellular proteolysis by hepatocyte growth factor activator inhibitor type 1 (HAI-1) in trophoblast cells.
Kohama K; Kawaguchi M; Fukushima T; Lin CY; Kataoka H
Hum Cell; 2012 Dec; 25(4):100-10. PubMed ID: 23248048
[TBL] [Abstract][Full Text] [Related]
12. Hepatocyte growth factor activator inhibitor type 1 regulates epithelial to mesenchymal transition through membrane-bound serine proteinases.
Cheng H; Fukushima T; Takahashi N; Tanaka H; Kataoka H
Cancer Res; 2009 Mar; 69(5):1828-35. PubMed ID: 19223533
[TBL] [Abstract][Full Text] [Related]
13. Reduced prostasin (CAP1/PRSS8) activity eliminates HAI-1 and HAI-2 deficiency-associated developmental defects by preventing matriptase activation.
Szabo R; Uzzun Sales K; Kosa P; Shylo NA; Godiksen S; Hansen KK; Friis S; Gutkind JS; Vogel LK; Hummler E; Camerer E; Bugge TH
PLoS Genet; 2012; 8(8):e1002937. PubMed ID: 22952456
[TBL] [Abstract][Full Text] [Related]
14. Hepatocyte growth factor activator inhibitor type 2 (HAI-2) modulates hepcidin expression by inhibiting the cell surface protease matriptase-2.
Maurer E; Gütschow M; Stirnberg M
Biochem J; 2013 Mar; 450(3):583-93. PubMed ID: 23293962
[TBL] [Abstract][Full Text] [Related]
15. White matter astrocytes produce hepatocyte growth factor activator inhibitor in human brain tissues.
Yamada T; Tsujioka Y; Taguchi J; Takahashi M; Tsuboi Y; Shimomura T
Exp Neurol; 1998 Sep; 153(1):60-4. PubMed ID: 9743567
[TBL] [Abstract][Full Text] [Related]
16. Involvement of hepatocyte growth factor in branching morphogenesis of murine salivary gland.
Ikari T; Hiraki A; Seki K; Sugiura T; Matsumoto K; Shirasuna K
Dev Dyn; 2003 Oct; 228(2):173-84. PubMed ID: 14517989
[TBL] [Abstract][Full Text] [Related]
17. Mouse zinc transporter 1 gene provides an essential function during early embryonic development.
Andrews GK; Wang H; Dey SK; Palmiter RD
Genesis; 2004 Oct; 40(2):74-81. PubMed ID: 15452870
[TBL] [Abstract][Full Text] [Related]
18. Identification of hepatocyte growth factor activator inhibitor type 2 (HAI-2)-related small peptide (H2RSP): its nuclear localization and generation of chimeric mRNA transcribed from both HAI-2 and H2RSP genes.
Itoh H; Kataoka H; Yamauchi M; Naganuma S; Akiyama Y; Nuki Y; Shimomura T; Miyazawa K; Kitamura N; Koono M
Biochem Biophys Res Commun; 2001 Oct; 288(2):390-9. PubMed ID: 11606055
[TBL] [Abstract][Full Text] [Related]
19. The glial cells missing-1 protein is essential for branching morphogenesis in the chorioallantoic placenta.
Anson-Cartwright L; Dawson K; Holmyard D; Fisher SJ; Lazzarini RA; Cross JC
Nat Genet; 2000 Jul; 25(3):311-4. PubMed ID: 10888880
[TBL] [Abstract][Full Text] [Related]
20. Hepatocyte growth factor activator inhibitor 2/placental bikunin (HAI-2/PB) gene is frequently hypermethylated in human hepatocellular carcinoma.
Fukai K; Yokosuka O; Chiba T; Hirasawa Y; Tada M; Imazeki F; Kataoka H; Saisho H
Cancer Res; 2003 Dec; 63(24):8674-9. PubMed ID: 14695180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
